Safety of Synchronous Rectal and Liver Resection 2
Introduction
Each year about 40,000 patients are newly diagnosed with rectal cancer and about 20,000 rectal cancer related deaths are documented in the United States. 1 Fifteen to 25% of patients present with synchronous liver metastasis at the time of diagnosis. 2, 3 Surgical resection of the primary tumor and the liver metastasis remains the only potential treatment for cure, with fiveyear survival rates between 25 to 40%. [4] [5] [6] [7] The traditional surgical strategy for colorectal cancer presenting with synchronous liver metastases has been to resect the primary cancer, followed by resection of the hepatic tumors after chemotherapy. [8] [9] [10] [11] Due to improved safety of hepatic surgery in recent years, the surgical management of synchronous disease has begun a paradigm change. Several experienced centers have reported safety of combined procedures for resection of colon cancer and synchronous colorectal cancer. 8, 9, [12] [13] [14] It is understandable that concerns remain regarding the perceived risks of combining pelvic surgery with hepatectomy. Few studies, however, have reported the actual clinical outcome of such combined rectal and liver resections. In the current study we present data from a tertiary referral center showing the safety and feasibility of simultaneous rectal and liver resections for stage IV rectal cancer. Committee on Cancer (AJCC). 15 Hepatic metastases were detected by combinations of computed tomography (CT), magnetic resonance imaging (MRI) and intraoperative ultrasound (IOUS). Preoperative comorbidities were classified as previously described. 14 Chemotherapy before rectal and/or hepatic resection included any systemic or regional chemotherapy with or without concomitant external beam radiation. Level of rectal primary was defined as the distance measured from the anal verge to the tumor at the time of pre-surgical evaluation. The rectal resections were classified according to the ASCRS textbook of Colon and Rectal Surgery. 16 The type of liver resection was defined by the Couinaud classification 17 . Resections of 3 or more contiguous liver segments were considered as a major liver procedure. 8 The technique for anesthetic management has been reported previously. 18 All patients were classified using the Clinical Risk Score defined by Fong. 7 All postoperative complications were captured for the entire hospitalization and for at least 30 days following rectal and/or hepatic resection. Complications were graded according to criteria described by Dindo et al. 19 Postoperative mortality included any death during postoperative hospitalization or within 30 days after rectal and/or hepatic procedure. Clinical data evaluated included total operation time, estimated blood loss, and length of hospitalization.
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For patients who underwent a staged treatment approach, complications and length of hospitalization were generated as the sum from rectal and liver procedure.
Statistical analysis
Univariate tests for differences between the simultaneous resection cohort and the staged resection cohort were conducted using Fisher's Exact test for categorical covariates and twosample t-tests for continuous covariates. ANOVA models were used to estimate correlations between several disease treatment variables such as length of hospitalization and size of metastases. Logistic regression was used to estimate the probability and odds ratios for several variables relating to complication severity. All statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC). A previous abdominal surgical procedure was documented in 20% of patients for both study groups (19.3% in simultaneous, 20.8% in staged group, p=NS).
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Tumor characteristics (Table 1)
Primary lesions
The level of the primary rectal cancer was similar in the two groups (median 9.0 vs. 9.9 cm, p=0.32). 
Hepatic lesions
With 5.6±3.6cm (median: 4.2cm) the mean size of the largest hepatic lesion was significantly larger (p<0.01) in the staged-resected study population compared to 2.7±2.3cm
(median: 2.0cm) in the simultaneously-resected group. The median number of metastasis was 2 in both groups (p=NS). In the simultaneous resection group 13% of patients (19 patients) with more than 5 metastases were identified, compared to 11% (6 patients) in staged resection patients (p= 0.81).
Neoadjuvant treatment
In the simultaneously-resected study population, 58 (40%) patients received chemotherapy only, 42 (29%) patients received chemoradiation and 4 (3%) patients received radiation only. The rest (41 patients; 28%) of this study population did not receive neoadjuvant treatment.
In the staged-resected study population for the rectal primary, 3 (6%) patients received chemotherapy only, 14 (26%) patients received chemoradiation and 9 (17%) patients received radiation only. The rest (27 patients; 51%) of this study population did not receive neoadjuvant treatment. Chemotherapy prior to liver resection was provided in 25 (47%) patients in the staged study population.
Surgical aspects (Table 2) Simultaneous treatments were performed by a midline laparotomy. Surgical treatment of primary rectal lesions mainly consisted of low anterior resection (LAR) in both groups (90% for simultaneous vs. 76% for staged; p<0.01). Pouch construction was performed in 38 (26%) The combined rates of positive resection margins for both procedures were 21% in the simultaneously-resected compared to 13% in the staged-resected group (p=0.31). The treatment approach did not result in a significant difference in the rate of R1 liver resections (simultaneous 11% vs. staged 6%; p=0.28). In 7.5% of patients in the staged group a positive resection margin at the rectal side was detected compared to 2.1% in the simultaneous group (p=0.08).
In neither of the groups was a patient was found to have positive resection margins in both the liver and the rectum. In the simultaneously-resected group 7.6% of patients underwent a R2 resection with pump placement for adjuvant chemotherapy for two-staged liver resection.
Total operation time was one and a half time longer for staged resection compared to the simultaneous approach (5.9±1.6 vs. 9.2±2.2 hours; p<0.01). Estimated mean blood loss was significantly less in the simultaneously-resected population (630±530 vs. 1200±760cc; p<0.01).
In both groups around 30% of patients required at least one transfusion of packed red blood cells (p=NS).
Outcome (Table 3)
Complications
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No peri-operative mortalities were noted for either the simultaneous or the staged resection approach. Overall, no significant differences were found between the two surgical approaches regarding the distribution of complication grading (p=0.30 Neither the type of rectal or liver procedure had an impact on the severity of complications (p=0.40; 0.19).
Hospitalization
The mean hospitalization for patients receiving simultaneous resections was significantly shorter when compared to patients treated with a staged approach (10±5 vs. 18±7 days; p<0.01).
Patients who underwent an APR had a longer mean hospitalization period of 3.8±1.4 days compared to patients who underwent a low anterior resection (LAR) (p=0.01). In addition, patients who were treated with a major liver resection had to stay significantly longer (4.9±0.9 days; p<0.01) in the hospital.
Adjuvant therapy
In the simultaneous group, 137 (95%) of patients received adjuvant chemotherapy. In the staged study population 46 (87%) patients received chemotherapy after staged liver resection (p=0.12). (Table 4) M A N U S C R I P T
Sub group major liver resections
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Sixty-nine patients (34.8%) underwent major liver resection, which was defined by removal of 3 or more consecutive liver segments, 30 of these (43.5%) received a simultaneous primary tumor resection.
Tumor characteristic/surgical aspects
The level of the rectal lesions in this sub group analysis did not show significant differences between staged and simultaneous-resected patients (10.1±5.0cm vs. 8.8±5.2cm;
p=0.29). The size of the largest liver lesion was slightly bigger in the staged resection group (4.7±3.3cm vs. 6.4±3.7cm; p=0.01), but 33% of patients in the simultaneous group were treated for more than 5 liver lesions, compared to only 8% in the staged study group (p=0.01).
Significantly more APR procedures were performed in the staged patient group (p<0.01)
Complications/outcome
No significant differences regarding postoperative complications were observed between the two treatment strategies (p=0.70). Details are shown in table 4. No peri-operative mortalities were reported in either group. The mean hospitalization period was significantly longer in staged resected patients (p<0.01).
Changes in Practice Over Time
The use of staged versus simultaneous resections for patients presenting with primary cancers in places as it related to time period is shown in Figure 1 . Before 2000, 51% of patients had a staged procedure. Since 2000, only six percent of patients have been treated with a staged procedure.
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Discussion
As almost a quarter of rectal cancer patients present with stage IV disease, the optimal timing of surgery for the primary and the liver disease has significant clinical implications. 20 Most centers still recommend a staged surgical approach with removal of the primary cancer first, followed by liver resection after adjuvant chemotherapy. 21, 22 This traditional standard posits that a simultaneous liver resection to be too challenging for these patients undergoing pelvic surgery. Combined procedures were considered to have prohibitive rates of morbidity and mortality. In particular, for patients requiring major liver resection, some results showing increased rates of morbidity and mortality have been reported. 8, 23 Recent improvements in the surgical and anesthetic techniques have greatly enhanced the safety of major operative procedures including pelvis procedures and hepatectomies. This has allowed a reconsideration of combined pelvic and hepatic procedures. Early series reporting simultaneous resections for stage IV colorectal cancer patients showed acceptable morbidity and mortality rates. [24] [25] [26] Nevertheless, most authors of prior studies recommended a simultaneous treatment approach only in patients with small liver lesions or with colon cancer. 27 In addition, the use of adjuvant chemotherapy after resection of the primary tumor before the liver resection has been advocated as providing oncologic benefit though without definitive supporting data. [28] [29] [30] Most of these prior recommendations are based on series with very small numbers of patients with rectal tumors 10, 13, 22 .
We have previously reported the safety of a simultaneous primary and liver resection approach for stage IV colon cancer patients 14 . The current manuscript is an extension of our previous work and documents the safety and feasibility of a combined treatment approach even for rectal cancer. In this retrospective study, only patients receiving the rectal as well as the liver procedure at MSKCC were included to provide uniform data documentation and surgical M A N U S C R I P T
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standards. This study design also demonstrates the patient selection criteria at a tertiary center for simultaneous resection. Thus, rectal tumors requiring APR were more likely to be chosen for a staged approach. Larger liver tumors requiring major liver resection were more likely to be chosen for a staged approach. This paper therefore shows not only the safety of a simultaneous approach, but also that such safety relies on patient selection by experienced surgeons.
The tendency to have sphincter preservation in the simultaneously-resected patients may also reflect the increasing numbers of sphincter preserving procedures after 2000. The option to preserve the sphincter has been optimized in recent years by better neoadjuvant treatment options, as well as by improvements in stapling devices and improvements in surgical techniques. [31] [32] [33] Similarly, a propensity for simultaneously-resected patients to have limited liver resections may reflect the trend for more parenchyma-sparing procedures during the last decade. 34, 35 In our study population, around 70% of simultaneously-resected patients received neoadjuvant chemotherapy compared to around 50 % of patients in the staged group. Smaller sizes of liver lesions might be caused by improved response of liver metastases to currently established neoadjuvant chemotherapy agents. 36, 37 In these simultaneous resection procedures, we prefer to perform the liver resection prior to the rectal procedure. 38 This order allows the "clean" liver procedure to be performed prior to the "contaminated" intestinal procedure. 39 During the hepatectomy, low fluid administration is generally used to prevent venous bleeding from the resection surface of the liver. 40, 41 Thus, performing the liver resection first minimizes the relative hypotension during this "low central venous pressure anesthesia" and allows fluid resuscitation during the rectal portion of the procedure. Furthermore, the venous congestion from the Pringle maneuver might endanger a newly created bowel anastomosis, if the rectal has been performed prior to the liver resection.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Safety of Synchronous Rectal and Liver Resection 14
The main message of this study is that combined procedures for stage IV rectal cancer patients are safe and feasible in carefully selected and evaluated patients at experienced centers.
The rates of complications between staged-and simultaneously-resected patients did not show statistical difference. Complication rates of this rectal study population were comparable with recently published studies combining stage IV colon cancer patients. 8, 12, 13 Mortality in this current series is also consistent with the mortality rate of 2 percent generally reported for rectal procedures alone 42 or for major liver resection alone 43 . In patients undergoing major liver resection, the rate of severe complications was acceptable with 23 percent for the simultaneous and 18% in the staged group, which is comparable with other studies. 44
This combined treatment approach resulted in lower total blood loss, shorter total operative time, and a shorter hospital stay. The economic benefits of reduction in hospitalization cost and more efficient OR utilization are clear. This simultaneous approach also allows faster recovery and initiation of chemotherapy. Furthermore, one cannot underestimate the psychological benefits of allowing a single procedure for eradication of all disease instead of employing two procedures scheduled over a period of months. The possibility that some patients will never be candidates for staged liver resection due to tumor progression under adjuvant chemotherapy will be eliminated by a synchronous resection approach. For example, in a Dutch study only 10% of patients presenting with stage IV colorectal cancer finally underwent liver resection. 45 In summary, our data show simultaneous resection of primary rectal cancer and liver metastases is safe for the majority of patients and is an efficient way to render surgical care. At 
